ERG expression can predict the outcome of docetaxel combinedwith androgen deprivation therapy in metastatic hormone-sensitiveprostate cancer.

Affiliation

University of Szeged, Department of Oncotherapy, Szeged, Hungary. Electronic address: [Email]

Abstract

Our study aimed to analyze the potential association between clinical parameters and ERG expression and the outcome of docetaxel chemotherapy among patients with metastatic hormone-sensitive prostate cancer.

Keywords

Chemosensitivity,Docetaxel chemotherapy,ERG,Hormone-sensitive prostate cancer,Metastatic prostate cancer,

OUR Recent Articles